nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—SLC22A5—Clonidine—glaucoma	0.243	0.549	CbGbCtD
Lomefloxacin—CYP1A2—Betaxolol—glaucoma	0.129	0.291	CbGbCtD
Lomefloxacin—CYP1A2—Clonidine—glaucoma	0.0704	0.159	CbGbCtD
Lomefloxacin—TOP2A—Alprenolol—Metipranolol—glaucoma	0.00322	0.588	CbGdCrCtD
Lomefloxacin—TOP2A—Alprenolol—Betaxolol—glaucoma	0.00225	0.412	CbGdCrCtD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—PEX19—glaucoma	0.00149	0.0997	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—ATOH7—glaucoma	0.000836	0.0558	CbGpPWpGaD
Lomefloxacin—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000622	0.0415	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000561	0.0375	CbGpPWpGaD
Lomefloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000427	0.0285	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000416	0.0278	CbGpPWpGaD
Lomefloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000388	0.0259	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00038	0.0254	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000357	0.0239	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Dorzolamide—glaucoma	0.000352	0.000655	CcSEcCtD
Lomefloxacin—Dyspnoea—Brinzolamide—glaucoma	0.000351	0.000652	CcSEcCtD
Lomefloxacin—Dyspepsia—Travoprost—glaucoma	0.000351	0.000652	CcSEcCtD
Lomefloxacin—Asthenia—Apraclonidine—glaucoma	0.00035	0.000651	CcSEcCtD
Lomefloxacin—Somnolence—Brinzolamide—glaucoma	0.00035	0.00065	CcSEcCtD
Lomefloxacin—Decreased appetite—Dorzolamide—glaucoma	0.000348	0.000647	CcSEcCtD
Lomefloxacin—Urticaria—Acetazolamide—glaucoma	0.000347	0.000645	CcSEcCtD
Lomefloxacin—Tremor—Clonidine—glaucoma	0.000347	0.000645	CcSEcCtD
Lomefloxacin—Dyspepsia—Brinzolamide—glaucoma	0.000346	0.000644	CcSEcCtD
Lomefloxacin—Pruritus—Apraclonidine—glaucoma	0.000345	0.000642	CcSEcCtD
Lomefloxacin—Fatigue—Dorzolamide—glaucoma	0.000345	0.000642	CcSEcCtD
Lomefloxacin—Tinnitus—Betaxolol—glaucoma	0.000345	0.000642	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000345	0.000641	CcSEcCtD
Lomefloxacin—Fatigue—Travoprost—glaucoma	0.000344	0.000639	CcSEcCtD
Lomefloxacin—Flushing—Betaxolol—glaucoma	0.000344	0.000639	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Clonidine—glaucoma	0.000343	0.000638	CcSEcCtD
Lomefloxacin—Insomnia—Pilocarpine—glaucoma	0.000342	0.000636	CcSEcCtD
Lomefloxacin—Decreased appetite—Brinzolamide—glaucoma	0.000342	0.000636	CcSEcCtD
Lomefloxacin—Constipation—Travoprost—glaucoma	0.000341	0.000634	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Timolol—glaucoma	0.000341	0.000634	CcSEcCtD
Lomefloxacin—Agitation—Clonidine—glaucoma	0.00034	0.000632	CcSEcCtD
Lomefloxacin—Paraesthesia—Pilocarpine—glaucoma	0.00034	0.000631	CcSEcCtD
Lomefloxacin—Asthenia—Bimatoprost—glaucoma	0.00034	0.000631	CcSEcCtD
Lomefloxacin—Fatigue—Brinzolamide—glaucoma	0.000339	0.000631	CcSEcCtD
Lomefloxacin—Angioedema—Clonidine—glaucoma	0.000338	0.000629	CcSEcCtD
Lomefloxacin—Dyspnoea—Pilocarpine—glaucoma	0.000337	0.000627	CcSEcCtD
Lomefloxacin—Somnolence—Pilocarpine—glaucoma	0.000336	0.000625	CcSEcCtD
Lomefloxacin—Pruritus—Bimatoprost—glaucoma	0.000335	0.000623	CcSEcCtD
Lomefloxacin—Diarrhoea—Apraclonidine—glaucoma	0.000334	0.000621	CcSEcCtD
Lomefloxacin—Malaise—Clonidine—glaucoma	0.000334	0.00062	CcSEcCtD
Lomefloxacin—Dyspepsia—Pilocarpine—glaucoma	0.000333	0.000619	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—OPN4—glaucoma	0.000333	0.0222	CbGpPWpGaD
Lomefloxacin—Chills—Betaxolol—glaucoma	0.000332	0.000617	CcSEcCtD
Lomefloxacin—Syncope—Clonidine—glaucoma	0.000332	0.000617	CcSEcCtD
Lomefloxacin—Arrhythmia—Betaxolol—glaucoma	0.000331	0.000615	CcSEcCtD
Lomefloxacin—Feeling abnormal—Dorzolamide—glaucoma	0.00033	0.000613	CcSEcCtD
Lomefloxacin—Decreased appetite—Pilocarpine—glaucoma	0.000329	0.000611	CcSEcCtD
Lomefloxacin—Feeling abnormal—Travoprost—glaucoma	0.000328	0.000611	CcSEcCtD
Lomefloxacin—Conjunctivitis—Timolol—glaucoma	0.000327	0.000609	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000327	0.000609	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Travoprost—glaucoma	0.000326	0.000606	CcSEcCtD
Lomefloxacin—Loss of consciousness—Clonidine—glaucoma	0.000325	0.000605	CcSEcCtD
Lomefloxacin—Feeling abnormal—Brinzolamide—glaucoma	0.000324	0.000603	CcSEcCtD
Lomefloxacin—Constipation—Pilocarpine—glaucoma	0.000323	0.000601	CcSEcCtD
Lomefloxacin—Cough—Clonidine—glaucoma	0.000323	0.0006	CcSEcCtD
Lomefloxacin—Dizziness—Apraclonidine—glaucoma	0.000323	0.0006	CcSEcCtD
Lomefloxacin—Urticaria—Dorzolamide—glaucoma	0.000318	0.000591	CcSEcCtD
Lomefloxacin—Epistaxis—Timolol—glaucoma	0.000318	0.000591	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IL1A—glaucoma	0.000317	0.0211	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Dorzolamide—glaucoma	0.000316	0.000588	CcSEcCtD
Lomefloxacin—Tension—Betaxolol—glaucoma	0.000316	0.000588	CcSEcCtD
Lomefloxacin—Dysgeusia—Betaxolol—glaucoma	0.000316	0.000587	CcSEcCtD
Lomefloxacin—Arthralgia—Clonidine—glaucoma	0.000315	0.000586	CcSEcCtD
Lomefloxacin—Chest pain—Clonidine—glaucoma	0.000315	0.000586	CcSEcCtD
Lomefloxacin—Abdominal pain—Travoprost—glaucoma	0.000315	0.000586	CcSEcCtD
Lomefloxacin—Agranulocytosis—Timolol—glaucoma	0.000314	0.000584	CcSEcCtD
Lomefloxacin—Anxiety—Clonidine—glaucoma	0.000314	0.000584	CcSEcCtD
Lomefloxacin—Asthenia—Acetazolamide—glaucoma	0.000313	0.000582	CcSEcCtD
Lomefloxacin—Dizziness—Bimatoprost—glaucoma	0.000313	0.000582	CcSEcCtD
Lomefloxacin—Nervousness—Betaxolol—glaucoma	0.000313	0.000582	CcSEcCtD
Lomefloxacin—Urticaria—Brinzolamide—glaucoma	0.000313	0.000581	CcSEcCtD
Lomefloxacin—Feeling abnormal—Pilocarpine—glaucoma	0.000312	0.000579	CcSEcCtD
Lomefloxacin—Discomfort—Clonidine—glaucoma	0.000311	0.000579	CcSEcCtD
Lomefloxacin—Vomiting—Apraclonidine—glaucoma	0.00031	0.000577	CcSEcCtD
Lomefloxacin—Muscle spasms—Betaxolol—glaucoma	0.00031	0.000576	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000309	0.000575	CcSEcCtD
Lomefloxacin—Hypersensitivity—Brimonidine—glaucoma	0.000309	0.000574	CcSEcCtD
Lomefloxacin—Dry mouth—Clonidine—glaucoma	0.000308	0.000573	CcSEcCtD
Lomefloxacin—Bradycardia—Timolol—glaucoma	0.000308	0.000572	CcSEcCtD
Lomefloxacin—Dermatitis—Apraclonidine—glaucoma	0.000308	0.000572	CcSEcCtD
Lomefloxacin—Headache—Apraclonidine—glaucoma	0.000306	0.000569	CcSEcCtD
Lomefloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000305	0.0204	CbGpPWpGaD
Lomefloxacin—Confusional state—Clonidine—glaucoma	0.000305	0.000566	CcSEcCtD
Lomefloxacin—Rhinitis—Timolol—glaucoma	0.000303	0.000564	CcSEcCtD
Lomefloxacin—Oedema—Clonidine—glaucoma	0.000302	0.000562	CcSEcCtD
Lomefloxacin—Tremor—Betaxolol—glaucoma	0.000302	0.000561	CcSEcCtD
Lomefloxacin—Hallucination—Timolol—glaucoma	0.000301	0.000559	CcSEcCtD
Lomefloxacin—Asthenia—Brimonidine—glaucoma	0.000301	0.000559	CcSEcCtD
Lomefloxacin—Abdominal pain—Pilocarpine—glaucoma	0.000299	0.000556	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Betaxolol—glaucoma	0.000299	0.000556	CcSEcCtD
Lomefloxacin—Diarrhoea—Acetazolamide—glaucoma	0.000299	0.000555	CcSEcCtD
Lomefloxacin—Rash—Bimatoprost—glaucoma	0.000298	0.000555	CcSEcCtD
Lomefloxacin—Dermatitis—Bimatoprost—glaucoma	0.000298	0.000554	CcSEcCtD
Lomefloxacin—Anaemia—Betaxolol—glaucoma	0.000298	0.000554	CcSEcCtD
Lomefloxacin—Shock—Clonidine—glaucoma	0.000297	0.000552	CcSEcCtD
Lomefloxacin—Pruritus—Brimonidine—glaucoma	0.000297	0.000551	CcSEcCtD
Lomefloxacin—Headache—Bimatoprost—glaucoma	0.000297	0.000551	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Clonidine—glaucoma	0.000296	0.00055	CcSEcCtD
Lomefloxacin—Hypersensitivity—Dorzolamide—glaucoma	0.000295	0.000548	CcSEcCtD
Lomefloxacin—Tachycardia—Clonidine—glaucoma	0.000295	0.000548	CcSEcCtD
Lomefloxacin—Hypersensitivity—Travoprost—glaucoma	0.000294	0.000546	CcSEcCtD
Lomefloxacin—Skin disorder—Clonidine—glaucoma	0.000293	0.000545	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Clonidine—glaucoma	0.000292	0.000543	CcSEcCtD
Lomefloxacin—Visual impairment—Timolol—glaucoma	0.000291	0.000542	CcSEcCtD
Lomefloxacin—Malaise—Betaxolol—glaucoma	0.000291	0.00054	CcSEcCtD
Lomefloxacin—Nausea—Apraclonidine—glaucoma	0.00029	0.000539	CcSEcCtD
Lomefloxacin—Hypersensitivity—Brinzolamide—glaucoma	0.00029	0.000539	CcSEcCtD
Lomefloxacin—Vertigo—Betaxolol—glaucoma	0.00029	0.000538	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000289	0.0193	CbGpPWpGaD
Lomefloxacin—Syncope—Betaxolol—glaucoma	0.000289	0.000537	CcSEcCtD
Lomefloxacin—Dizziness—Acetazolamide—glaucoma	0.000289	0.000537	CcSEcCtD
Lomefloxacin—Anorexia—Clonidine—glaucoma	0.000288	0.000535	CcSEcCtD
Lomefloxacin—Asthenia—Dorzolamide—glaucoma	0.000287	0.000534	CcSEcCtD
Lomefloxacin—Asthenia—Travoprost—glaucoma	0.000286	0.000532	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000284	0.0189	CbGpPWpGaD
Lomefloxacin—Pruritus—Dorzolamide—glaucoma	0.000283	0.000526	CcSEcCtD
Lomefloxacin—Loss of consciousness—Betaxolol—glaucoma	0.000283	0.000526	CcSEcCtD
Lomefloxacin—Asthenia—Brinzolamide—glaucoma	0.000282	0.000525	CcSEcCtD
Lomefloxacin—Hypotension—Clonidine—glaucoma	0.000282	0.000525	CcSEcCtD
Lomefloxacin—Pruritus—Travoprost—glaucoma	0.000282	0.000524	CcSEcCtD
Lomefloxacin—Tinnitus—Timolol—glaucoma	0.000282	0.000524	CcSEcCtD
Lomefloxacin—Cough—Betaxolol—glaucoma	0.000281	0.000523	CcSEcCtD
Lomefloxacin—Nausea—Bimatoprost—glaucoma	0.000281	0.000523	CcSEcCtD
Lomefloxacin—Hypersensitivity—Pilocarpine—glaucoma	0.000279	0.000518	CcSEcCtD
Lomefloxacin—Pruritus—Brinzolamide—glaucoma	0.000278	0.000518	CcSEcCtD
Lomefloxacin—Vomiting—Acetazolamide—glaucoma	0.000278	0.000516	CcSEcCtD
Lomefloxacin—Dizziness—Brimonidine—glaucoma	0.000277	0.000515	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000275	0.000512	CcSEcCtD
Lomefloxacin—Arthralgia—Betaxolol—glaucoma	0.000274	0.00051	CcSEcCtD
Lomefloxacin—Chest pain—Betaxolol—glaucoma	0.000274	0.00051	CcSEcCtD
Lomefloxacin—Myalgia—Betaxolol—glaucoma	0.000274	0.00051	CcSEcCtD
Lomefloxacin—Diarrhoea—Dorzolamide—glaucoma	0.000274	0.000509	CcSEcCtD
Lomefloxacin—Headache—Acetazolamide—glaucoma	0.000274	0.000509	CcSEcCtD
Lomefloxacin—Anxiety—Betaxolol—glaucoma	0.000273	0.000508	CcSEcCtD
Lomefloxacin—Insomnia—Clonidine—glaucoma	0.000273	0.000508	CcSEcCtD
Lomefloxacin—Diarrhoea—Travoprost—glaucoma	0.000273	0.000507	CcSEcCtD
Lomefloxacin—Asthenia—Pilocarpine—glaucoma	0.000271	0.000505	CcSEcCtD
Lomefloxacin—Paraesthesia—Clonidine—glaucoma	0.000271	0.000504	CcSEcCtD
Lomefloxacin—Discomfort—Betaxolol—glaucoma	0.000271	0.000504	CcSEcCtD
Lomefloxacin—Arrhythmia—Timolol—glaucoma	0.00027	0.000502	CcSEcCtD
Lomefloxacin—Dyspnoea—Clonidine—glaucoma	0.000269	0.000501	CcSEcCtD
Lomefloxacin—Diarrhoea—Brinzolamide—glaucoma	0.000269	0.000501	CcSEcCtD
Lomefloxacin—Somnolence—Clonidine—glaucoma	0.000269	0.000499	CcSEcCtD
Lomefloxacin—Dry mouth—Betaxolol—glaucoma	0.000268	0.000499	CcSEcCtD
Lomefloxacin—Pruritus—Pilocarpine—glaucoma	0.000268	0.000497	CcSEcCtD
Lomefloxacin—Confusional state—Betaxolol—glaucoma	0.000265	0.000493	CcSEcCtD
Lomefloxacin—Dizziness—Dorzolamide—glaucoma	0.000265	0.000492	CcSEcCtD
Lomefloxacin—Rash—Brimonidine—glaucoma	0.000264	0.000491	CcSEcCtD
Lomefloxacin—Dermatitis—Brimonidine—glaucoma	0.000264	0.000491	CcSEcCtD
Lomefloxacin—Dizziness—Travoprost—glaucoma	0.000264	0.00049	CcSEcCtD
Lomefloxacin—Oedema—Betaxolol—glaucoma	0.000263	0.000489	CcSEcCtD
Lomefloxacin—Headache—Brimonidine—glaucoma	0.000263	0.000488	CcSEcCtD
Lomefloxacin—Decreased appetite—Clonidine—glaucoma	0.000263	0.000488	CcSEcCtD
Lomefloxacin—Fatigue—Clonidine—glaucoma	0.00026	0.000484	CcSEcCtD
Lomefloxacin—Dizziness—Brinzolamide—glaucoma	0.00026	0.000484	CcSEcCtD
Lomefloxacin—Nausea—Acetazolamide—glaucoma	0.000259	0.000482	CcSEcCtD
Lomefloxacin—Diarrhoea—Pilocarpine—glaucoma	0.000259	0.000481	CcSEcCtD
Lomefloxacin—Shock—Betaxolol—glaucoma	0.000259	0.000481	CcSEcCtD
Lomefloxacin—Tension—Timolol—glaucoma	0.000258	0.00048	CcSEcCtD
Lomefloxacin—Constipation—Clonidine—glaucoma	0.000258	0.00048	CcSEcCtD
Lomefloxacin—Dysgeusia—Timolol—glaucoma	0.000258	0.000479	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Betaxolol—glaucoma	0.000257	0.000479	CcSEcCtD
Lomefloxacin—Tachycardia—Betaxolol—glaucoma	0.000257	0.000477	CcSEcCtD
Lomefloxacin—Nervousness—Timolol—glaucoma	0.000256	0.000475	CcSEcCtD
Lomefloxacin—Skin disorder—Betaxolol—glaucoma	0.000255	0.000475	CcSEcCtD
Lomefloxacin—Vomiting—Dorzolamide—glaucoma	0.000255	0.000473	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Betaxolol—glaucoma	0.000254	0.000473	CcSEcCtD
Lomefloxacin—Rash—Dorzolamide—glaucoma	0.000252	0.000469	CcSEcCtD
Lomefloxacin—Dermatitis—Dorzolamide—glaucoma	0.000252	0.000469	CcSEcCtD
Lomefloxacin—Rash—Travoprost—glaucoma	0.000251	0.000467	CcSEcCtD
Lomefloxacin—Dermatitis—Travoprost—glaucoma	0.000251	0.000467	CcSEcCtD
Lomefloxacin—Headache—Dorzolamide—glaucoma	0.000251	0.000466	CcSEcCtD
Lomefloxacin—Anorexia—Betaxolol—glaucoma	0.000251	0.000466	CcSEcCtD
Lomefloxacin—Vomiting—Brinzolamide—glaucoma	0.00025	0.000465	CcSEcCtD
Lomefloxacin—Dizziness—Pilocarpine—glaucoma	0.00025	0.000465	CcSEcCtD
Lomefloxacin—Headache—Travoprost—glaucoma	0.00025	0.000464	CcSEcCtD
Lomefloxacin—Nausea—Brimonidine—glaucoma	0.000249	0.000463	CcSEcCtD
Lomefloxacin—Feeling abnormal—Clonidine—glaucoma	0.000249	0.000463	CcSEcCtD
Lomefloxacin—Rash—Brinzolamide—glaucoma	0.000248	0.000461	CcSEcCtD
Lomefloxacin—Dermatitis—Brinzolamide—glaucoma	0.000248	0.000461	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Clonidine—glaucoma	0.000247	0.000459	CcSEcCtD
Lomefloxacin—Headache—Brinzolamide—glaucoma	0.000247	0.000458	CcSEcCtD
Lomefloxacin—Hypotension—Betaxolol—glaucoma	0.000246	0.000457	CcSEcCtD
Lomefloxacin—Angioedema—Timolol—glaucoma	0.000241	0.000447	CcSEcCtD
Lomefloxacin—Vomiting—Pilocarpine—glaucoma	0.00024	0.000447	CcSEcCtD
Lomefloxacin—Urticaria—Clonidine—glaucoma	0.00024	0.000446	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00024	0.000445	CcSEcCtD
Lomefloxacin—Abdominal pain—Clonidine—glaucoma	0.000239	0.000444	CcSEcCtD
Lomefloxacin—Rash—Pilocarpine—glaucoma	0.000238	0.000443	CcSEcCtD
Lomefloxacin—Dermatitis—Pilocarpine—glaucoma	0.000238	0.000443	CcSEcCtD
Lomefloxacin—Insomnia—Betaxolol—glaucoma	0.000238	0.000442	CcSEcCtD
Lomefloxacin—Nausea—Dorzolamide—glaucoma	0.000238	0.000442	CcSEcCtD
Lomefloxacin—Headache—Pilocarpine—glaucoma	0.000237	0.000441	CcSEcCtD
Lomefloxacin—Nausea—Travoprost—glaucoma	0.000237	0.00044	CcSEcCtD
Lomefloxacin—Vertigo—Timolol—glaucoma	0.000237	0.00044	CcSEcCtD
Lomefloxacin—Paraesthesia—Betaxolol—glaucoma	0.000236	0.000439	CcSEcCtD
Lomefloxacin—Syncope—Timolol—glaucoma	0.000236	0.000439	CcSEcCtD
Lomefloxacin—Dyspnoea—Betaxolol—glaucoma	0.000234	0.000436	CcSEcCtD
Lomefloxacin—Nausea—Brinzolamide—glaucoma	0.000234	0.000435	CcSEcCtD
Lomefloxacin—Dyspepsia—Betaxolol—glaucoma	0.000231	0.00043	CcSEcCtD
Lomefloxacin—Loss of consciousness—Timolol—glaucoma	0.000231	0.00043	CcSEcCtD
Lomefloxacin—Cough—Timolol—glaucoma	0.00023	0.000427	CcSEcCtD
Lomefloxacin—Decreased appetite—Betaxolol—glaucoma	0.000229	0.000425	CcSEcCtD
Lomefloxacin—Hypertension—Timolol—glaucoma	0.000227	0.000422	CcSEcCtD
Lomefloxacin—Fatigue—Betaxolol—glaucoma	0.000227	0.000421	CcSEcCtD
Lomefloxacin—Constipation—Betaxolol—glaucoma	0.000225	0.000418	CcSEcCtD
Lomefloxacin—Nausea—Pilocarpine—glaucoma	0.000225	0.000418	CcSEcCtD
Lomefloxacin—Myalgia—Timolol—glaucoma	0.000224	0.000417	CcSEcCtD
Lomefloxacin—Chest pain—Timolol—glaucoma	0.000224	0.000417	CcSEcCtD
Lomefloxacin—Arthralgia—Timolol—glaucoma	0.000224	0.000417	CcSEcCtD
Lomefloxacin—Anxiety—Timolol—glaucoma	0.000223	0.000415	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000223	0.0149	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Clonidine—glaucoma	0.000223	0.000414	CcSEcCtD
Lomefloxacin—Discomfort—Timolol—glaucoma	0.000221	0.000412	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.00022	0.0147	CbGpPWpGaD
Lomefloxacin—Dry mouth—Timolol—glaucoma	0.000219	0.000407	CcSEcCtD
Lomefloxacin—Asthenia—Clonidine—glaucoma	0.000217	0.000403	CcSEcCtD
Lomefloxacin—Feeling abnormal—Betaxolol—glaucoma	0.000217	0.000403	CcSEcCtD
Lomefloxacin—Confusional state—Timolol—glaucoma	0.000217	0.000403	CcSEcCtD
Lomefloxacin—Oedema—Timolol—glaucoma	0.000215	0.000399	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Timolol—glaucoma	0.000215	0.000399	CcSEcCtD
Lomefloxacin—Pruritus—Clonidine—glaucoma	0.000214	0.000397	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PEX19—glaucoma	0.000213	0.0142	CbGpPWpGaD
Lomefloxacin—Shock—Timolol—glaucoma	0.000211	0.000393	CcSEcCtD
Lomefloxacin—Urticaria—Betaxolol—glaucoma	0.000209	0.000388	CcSEcCtD
Lomefloxacin—Skin disorder—Timolol—glaucoma	0.000209	0.000388	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Timolol—glaucoma	0.000208	0.000386	CcSEcCtD
Lomefloxacin—Diarrhoea—Clonidine—glaucoma	0.000207	0.000384	CcSEcCtD
Lomefloxacin—Anorexia—Timolol—glaucoma	0.000205	0.000381	CcSEcCtD
Lomefloxacin—Hypotension—Timolol—glaucoma	0.000201	0.000373	CcSEcCtD
Lomefloxacin—Dizziness—Clonidine—glaucoma	0.0002	0.000371	CcSEcCtD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000197	0.0132	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Timolol—glaucoma	0.000196	0.000364	CcSEcCtD
Lomefloxacin—Insomnia—Timolol—glaucoma	0.000194	0.000361	CcSEcCtD
Lomefloxacin—Hypersensitivity—Betaxolol—glaucoma	0.000194	0.00036	CcSEcCtD
Lomefloxacin—Paraesthesia—Timolol—glaucoma	0.000193	0.000359	CcSEcCtD
Lomefloxacin—Vomiting—Clonidine—glaucoma	0.000192	0.000357	CcSEcCtD
Lomefloxacin—Dyspnoea—Timolol—glaucoma	0.000192	0.000356	CcSEcCtD
Lomefloxacin—Somnolence—Timolol—glaucoma	0.000191	0.000355	CcSEcCtD
Lomefloxacin—Rash—Clonidine—glaucoma	0.00019	0.000354	CcSEcCtD
Lomefloxacin—Dermatitis—Clonidine—glaucoma	0.00019	0.000354	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.00019	0.0127	CbGpPWpGaD
Lomefloxacin—Headache—Clonidine—glaucoma	0.000189	0.000352	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000189	0.0126	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Timolol—glaucoma	0.000189	0.000352	CcSEcCtD
Lomefloxacin—Asthenia—Betaxolol—glaucoma	0.000189	0.000351	CcSEcCtD
Lomefloxacin—Decreased appetite—Timolol—glaucoma	0.000187	0.000347	CcSEcCtD
Lomefloxacin—Pruritus—Betaxolol—glaucoma	0.000186	0.000346	CcSEcCtD
Lomefloxacin—Fatigue—Timolol—glaucoma	0.000185	0.000344	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—TXN—glaucoma	0.00018	0.012	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Betaxolol—glaucoma	0.00018	0.000334	CcSEcCtD
Lomefloxacin—Nausea—Clonidine—glaucoma	0.000179	0.000334	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000178	0.0119	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Timolol—glaucoma	0.000177	0.000329	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Timolol—glaucoma	0.000176	0.000327	CcSEcCtD
Lomefloxacin—Dizziness—Betaxolol—glaucoma	0.000174	0.000323	CcSEcCtD
Lomefloxacin—Urticaria—Timolol—glaucoma	0.000171	0.000317	CcSEcCtD
Lomefloxacin—Abdominal pain—Timolol—glaucoma	0.00017	0.000316	CcSEcCtD
Lomefloxacin—Vomiting—Betaxolol—glaucoma	0.000167	0.000311	CcSEcCtD
Lomefloxacin—Rash—Betaxolol—glaucoma	0.000166	0.000308	CcSEcCtD
Lomefloxacin—Dermatitis—Betaxolol—glaucoma	0.000166	0.000308	CcSEcCtD
Lomefloxacin—Headache—Betaxolol—glaucoma	0.000165	0.000306	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000161	0.0107	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000159	0.0106	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Timolol—glaucoma	0.000158	0.000294	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000157	0.0105	CbGpPWpGaD
Lomefloxacin—Nausea—Betaxolol—glaucoma	0.000156	0.00029	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000156	0.0104	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000156	0.0104	CbGpPWpGaD
Lomefloxacin—Asthenia—Timolol—glaucoma	0.000154	0.000287	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000152	0.0102	CbGpPWpGaD
Lomefloxacin—Pruritus—Timolol—glaucoma	0.000152	0.000283	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—glaucoma	0.000147	0.00984	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Timolol—glaucoma	0.000147	0.000273	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000147	0.00979	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000144	0.00962	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000143	0.00953	CbGpPWpGaD
Lomefloxacin—Dizziness—Timolol—glaucoma	0.000142	0.000264	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—FGFR1OP—glaucoma	0.000139	0.00931	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000138	0.00925	CbGpPWpGaD
Lomefloxacin—Vomiting—Timolol—glaucoma	0.000137	0.000254	CcSEcCtD
Lomefloxacin—Rash—Timolol—glaucoma	0.000135	0.000252	CcSEcCtD
Lomefloxacin—Dermatitis—Timolol—glaucoma	0.000135	0.000252	CcSEcCtD
Lomefloxacin—Headache—Timolol—glaucoma	0.000135	0.00025	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000134	0.00896	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—RAB8A—glaucoma	0.000131	0.00876	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.000131	0.00875	CbGpPWpGaD
Lomefloxacin—Nausea—Timolol—glaucoma	0.000128	0.000237	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000127	0.00849	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000123	0.00823	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NGFR—glaucoma	0.000119	0.00792	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000117	0.00783	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—OPTN—glaucoma	0.000114	0.00759	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NTRK1—glaucoma	0.000113	0.00752	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000108	0.00722	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000107	0.00717	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000105	0.00704	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000105	0.00703	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000105	0.00703	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000105	0.00703	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000103	0.00686	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.0001	0.00669	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	9.85e-05	0.00658	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.61e-05	0.00642	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.19e-05	0.00614	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTM1—glaucoma	8.9e-05	0.00595	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—FAS—glaucoma	8.82e-05	0.00589	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.51e-05	0.00569	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.4e-05	0.00561	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—glaucoma	8.16e-05	0.00545	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTT1—glaucoma	7.87e-05	0.00525	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	7.86e-05	0.00525	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—glaucoma	7.23e-05	0.00483	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.04e-05	0.0047	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.03e-05	0.00469	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.9e-05	0.00461	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—glaucoma	6.45e-05	0.00431	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—glaucoma	5.84e-05	0.0039	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	5.78e-05	0.00386	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.47e-05	0.00366	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—glaucoma	5.23e-05	0.0035	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND2—glaucoma	5.22e-05	0.00349	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.15e-05	0.00344	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—glaucoma	5.01e-05	0.00335	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	4.75e-05	0.00317	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2B—glaucoma	4.68e-05	0.00313	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.6e-05	0.00307	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.55e-05	0.00304	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.49e-05	0.003	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.49e-05	0.003	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.44e-05	0.00297	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.9e-05	0.00261	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.74e-05	0.0025	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.67e-05	0.00245	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.62e-05	0.00241	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.44e-05	0.0023	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.42e-05	0.00229	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—glaucoma	3.3e-05	0.00221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NARFL—glaucoma	3.22e-05	0.00215	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA5A—glaucoma	3.22e-05	0.00215	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.2e-05	0.00214	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.2e-05	0.00214	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	2.99e-05	0.002	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.93e-05	0.00196	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.89e-05	0.00193	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—glaucoma	2.68e-05	0.00179	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	2.65e-05	0.00177	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1B—glaucoma	2.37e-05	0.00158	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA1—glaucoma	1.57e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CTSA—glaucoma	1.53e-05	0.00102	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—glaucoma	1.49e-05	0.000995	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA2—glaucoma	1.44e-05	0.000962	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.41e-05	0.00094	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.41e-05	0.00094	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TXN—glaucoma	1.01e-05	0.000678	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.26e-06	0.000618	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.17e-06	0.000613	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—glaucoma	7.87e-06	0.000526	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.35e-06	0.000424	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1B1—glaucoma	6.27e-06	0.000419	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCA1—glaucoma	6.27e-06	0.000419	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—glaucoma	5.01e-06	0.000335	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—glaucoma	4.43e-06	0.000296	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOE—glaucoma	4.12e-06	0.000275	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAV1—glaucoma	4.09e-06	0.000273	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NOS3—glaucoma	3.09e-06	0.000206	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—glaucoma	2.83e-06	0.000189	CbGpPWpGaD
